McDermott Will & Emery represented Young Innovations, Inc. (Nasdaq: YDNT) in connection with its acquisition by an affiliate of Linden Capital Partners, a Chicago-based private equity firm, for approximately $314 million.
Young Innovations is a leading U.S. manufacturer and distributor of supplies and equipment used by dentists, dental hygienists, dental assistants and consumers.
The Merger Agreement, entered into on December 4, 2012, includes a 40-day go-shop period. Under the terms of the agreement, holders of outstanding shares of common stock of Young Innovations will receive $39.50 per share, representing a 12.5% premium to the 30-day average closing stock price. If the merger is approved by shareholders, the transaction is expected to close by March 29, 2013. When the acquisition is completed, Young Innovations will become a private company, wholly owned by the affiliate of Linden.
“This transaction reflects the success of Young Innovations as a leading manufacturer and supplier of dental equipment,” said Corporate partner John Tamisiea who led the McDermott team. “We are enormously pleased to have represented Young Innovations for over 13 years and on this acquisition that will deliver significant value to their shareholders.”
In addition to Mr. Tamisiea, the McDermott transaction team included partners Samuel Wales, John Hammond, Daniel Zucker, James Cohen, Jennifer Mikulina, Ruth Wimer, Maureen O’Brien, Carla Hine and Mark Bilut, as well as associates Brian Singer, Mathew Rupp, Ulrika Mattsson and Joseph Urwitz.
McDermott’s mergers and acquisitions (M&A) practice provides clients sophisticated, legal counsel for both domestic and cross-border transactions. Our lawyers advise U.S. and multinational corporations, private equity funds, emerging companies and venture-funded start ups on the full range of M&A needs involving publicly traded and privately owned companies.
